BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22018462)

  • 1. Identification of small-molecule inhibitors of Trypansoma cruzi replication.
    Germain AR; Carmody LC; Dockendorff C; Galan-Rodriguez C; Rodriguez A; Johnston S; Bittker JA; MacPherson L; Dandapani S; Palmer M; Schreiber SL; Munoz B
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7197-200. PubMed ID: 22018462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
    Alvarez G; Aguirre-López B; Varela J; Cabrera M; Merlino A; López GV; Lavaggi ML; Porcal W; Di Maio R; González M; Cerecetto H; Cabrera N; Pérez-Montfort R; de Gómez-Puyou MT; Gómez-Puyou A
    Eur J Med Chem; 2010 Dec; 45(12):5767-72. PubMed ID: 20889239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
    Keenan M; Abbott MJ; Alexander PW; Armstrong T; Best WM; Berven B; Botero A; Chaplin JH; Charman SA; Chatelain E; von Geldern TW; Kerfoot M; Khong A; Nguyen T; McManus JD; Morizzi J; Ryan E; Scandale I; Thompson RA; Wang SZ; White KL
    J Med Chem; 2012 May; 55(9):4189-204. PubMed ID: 22536986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
    de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
    Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes).
    Schvartzapel AJ; Zhong L; Docampo R; Rodriguez JB; Gros EG
    J Med Chem; 1997 Jul; 40(15):2314-22. PubMed ID: 9240347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms.
    Carneiro PF; do Nascimento SB; Pinto AV; Pinto Mdo C; Lechuga GC; Santos DO; dos Santos Júnior HM; Resende JA; Bourguignon SC; Ferreira VF
    Bioorg Med Chem; 2012 Aug; 20(16):4995-5000. PubMed ID: 22795899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
    da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV
    Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.
    Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC
    Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological characterization of new aryloxyindole-4,9-diones as potent trypanosomicidal agents.
    Tapia RA; Salas CO; Vázquez K; Espinosa-Bustos C; Soto-Delgado J; Varela J; Birriel E; Cerecetto H; González M; Paulino M
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3919-22. PubMed ID: 25008454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi.
    Cinque GM; Szajnman SH; Zhong L; Docampo R; Schvartzapel AJ; Rodriguez JB; Gros EG
    J Med Chem; 1998 Apr; 41(9):1540-54. PubMed ID: 9554887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruzi.
    Costa LB; Cardoso MV; de Oliveira Filho GB; de Moraes Gomes PA; Espíndola JW; de Jesus Silva TG; Torres PH; Silva Junior FP; Martin J; de Figueiredo RC; Leite AC
    Bioorg Med Chem; 2016 Apr; 24(8):1608-18. PubMed ID: 26964673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi.
    Esteva MI; Kettler K; Maidana C; Fichera L; Ruiz AM; Bontempi EJ; Andersson B; Dahse HM; Haebel P; Ortmann R; Klebe G; Schlitzer M
    J Med Chem; 2005 Nov; 48(23):7186-91. PubMed ID: 16279776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmanicidal and trypanocidal activities of 2-aminocyclohexanol and 1,2-cyclohexanediamine derivatives.
    Rebollo O; del Olmo E; Ruiz G; López-Pérez JL; Giménez A; San Feliciano A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):184-7. PubMed ID: 18024033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro trypanocidal activity of some novel iron chelating agents.
    Singh PK; Jones MM; Lane JE; Nesset A; Zimmerman LJ; Ribeiro-Rodrigues R; Richter A; Stenger MR; Carter CE
    Arzneimittelforschung; 1997 Mar; 47(3):311-5. PubMed ID: 9105552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naftifine-analogues as anti-Trypanosoma cruzi agents.
    Gerpe A; Boiani L; Hernández P; Sortino M; Zacchino S; González M; Cerecetto H
    Eur J Med Chem; 2010 Jun; 45(6):2154-64. PubMed ID: 20163894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
    Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N
    Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of naphthofuranquinones with activity against Trypanosoma cruzi.
    Silva RS; Costa EM; Trindade UL; Teixeira DV; Pinto Mde C; Santos GL; Malta VR; De Simone CA; Pinto AV; de Castro SL
    Eur J Med Chem; 2006 Apr; 41(4):526-30. PubMed ID: 16500733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
    Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
    J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
    Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
    Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.